AMSTERDAM, THE NETHERLANDS--(Marketwire - Sep 18, 2012) - AkzoNobel's Supervisory Board today
announced that CEO Ton Büchner is taking a
leave of absence as a result of a medical condition. This decision has been
based on medical advice following Ton Büchner being diagnosed with
fatigue. His recovery is expected to enable him to return to work in the first
half of October.
In the meantime, the Supervisory Board has asked CFO Keith Nichols to
and be first point of contact on the Executive Committee. Antony Burgmans,
member of the Supervisory Board, will be on hand to offer advice and support
Keith and the Executive Committee.
"I was sad to learn about Ton's condition and we all look forward to seeing
back in the office shortly", said Karel Vuursteen, Chairman of the Supervisory
Board. "However, in the meantime we have a highly experienced Executive
Committee and, together with Keith, they will provide strong leadership until
Ton is back."
The company will publish its Q3 results on October 18. The investor meeting
planned for October 22 will be postponed until further notice.
- - -
AkzoNobel is the largest global paints and coatings company and a major
of specialty chemicals. We supply industries and consumers worldwide with
innovative products and are passionate about developing sustainable answers
our customers. Our portfolio includes well known brands such as Dulux,
International and Eka. Headquartered in Amsterdam, the Netherlands, we are
consistently ranked as one of the leaders in the area of sustainability. With
operations in more than 80 countries, our 55,000 people around the world are
committed to excellence and delivering Tomorrow's Answers Today™.
Pdf file AkzoNobel press release:
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Akzo Nobel NV via Thomson Reuters ONE